Welcome to the new version of CaltechAUTHORS. Login is currently restricted to library staff. If you notice any issues, please email coda@library.caltech.edu
Published February 2020 | Supplemental Material + Accepted Version
Journal Article Open

Tissue clearing and its applications in neuroscience


State-of-the-art tissue-clearing methods provide subcellular-level optical access to intact tissues from individual organs and even to some entire mammals. When combined with light-sheet microscopy and automated approaches to image analysis, existing tissue-clearing methods can speed up and may reduce the cost of conventional histology by several orders of magnitude. In addition, tissue-clearing chemistry allows whole-organ antibody labelling, which can be applied even to thick human tissues. By combining the most powerful labelling, clearing, imaging and data-analysis tools, scientists are extracting structural and functional cellular and subcellular information on complex mammalian bodies and large human specimens at an accelerated pace. The rapid generation of terabyte-scale imaging data furthermore creates a high demand for efficient computational approaches that tackle challenges in large-scale data analysis and management. In this Review, we discuss how tissue-clearing methods could provide an unbiased, system-level view of mammalian bodies and human specimens and discuss future opportunities for the use of these methods in human neuroscience.

Additional Information

© 2020 Springer Nature Limited. Accepted 18 November 2019; Published 02 January 2020. The authors thank E. A. Susaki for help in compiling Table 1 and Supplementary Table 1 for current tissue-clearing protocols and reagents, K. Matsumoto and Y. Shinohara for drawing the chemical structures in the supplementary information, T. Mano for contributing to the CUBIC figure, R. Cai and C. Pan for contributing to the uDISCO figure, S. R. Kumar, G. M. Coughlin, R. Challis and C. Challis for contributing to the viral-assisted spectral tracing figure and Y.-G. Park, C. H. Sohn, T. Ku, V. Lilascharoen and B. K. Lim for contributing to the SHIELD figure. The authors also gratefully acknowledge grant support from Brain/MINDS, the Basic Science and Platform Technology Program for Innovative Biological Medicine (AMED/MEXT), the Japan Society for the Promotion of Science (Grant-in-Aid for Scientific Research (S)) and the Human Frontier Science Program Research Grant Program (HFSP RGP0019/2018) (H.R.U.), the Munich Cluster for Systems Neurology (SyNergy), the Fritz Thyssen Stiftung and the Deutsche Forschungsgemeinschaft (A.E.), the David and Lucile Packard Foundation (Packard Fellowship), the McKnight Foundation, the US National Institutes of Health (NIH) (1-DP2-ES027992; U01MH117072), the NCSOFT Cultural Foundation and the Koreaan Institute for Basic Science (IBS-R026-D1) (K.C.), the NIH BRAIN Initiative, the NIH Office of the Director and the US National Science Foundation (NeuroNex) (V.G.), LABEX LIFESENSES (reference ANR-10-LABX-65) managed by the French Agence National de la Recherche within the Investissements d'Avenir programme under reference ANR-11-IDEX-0004-02 (A.C.), the European Regional Development Fund in the framework of the Czech IT4Innovations National Supercomputing Center path to exascale project, project number CZ.02.1.01/0.0/0.0/16_013/0001791, within the Czech Research, Development and Education Operational Programme (P.T.) and the Howard Hughes Medical Institute (P.J.K.). Author Contributions: H.R.U., A.E., K.C., V.G., A.C. and P.J.K. researched data for the article. All the authors contributed to substantial discussion of its content, wrote the article and reviewed and edited the manuscript before submission. Competing interests: H.R.U. is a co-inventor on a patent applications covering the CUBIC reagents (PCT/JP2014/070618 (pending), patent applicant is RIKEN, other co-inventors are E. A. Susaki and K. Tainaka; PCT/JP2017/016410 (pending), patent applicant is RIKEN, other co-inventors are K. Tainaka and T. Murakami) and a co-founder of CUBICStars Inc. A.E. is the applicant and the inventor on a patent application for technologies relating to vDISCO clearing (PCT/EP2018/063098 (pending)). K.C. is the inventor or a co-inventor on patents and patent applications for CLARITY (PCT/US2013/031066 (active), patent applicant is Stanford University, co-inventor is K. A. Deisseroth), stochastic electrotransport (PCT/US2015/024297 (active), patent applicant is MIT), SHIELD (PCT/US2016/064538 (pending), applicant is Massachusetts Institute of Technology (MIT), other co-inventors are E. Murray and J. H. Cho), SWITCH (PCT/US2016/064538 (pending), applicant is MIT, other co-inventors are E. Murray and J. H. Cho) and MAP (PCT/US2017/030285 (pending), applicant is MIT, other co-inventors are T. Ku, J. M. Swaney and J. Y. Park) and a co-founder of LifeCanvas Technologies. V.G. is a co-inventor on patent applications covering PACT and PARS (PCT/US2014/048985 (active), applicant is California Institute of Technology, other co-inventors are V. Gradinaru and B. Yang) and adeno-associated virus (US14/485,024 (active), applicant is California Institute of Technology, other co-inventors are B. E. Deverman, P. H. Patterson and V. Gradinaru) technologies. P.J.K. is an inventor or co-inventor on patents and patent applications covering multiview imaging (US14/049,470 (active), applicant is Howard Hughes Medical Institute) and adaptive light-sheet microscopy (PCT/US2017/038970 (pending), applicant is Howard Hughes Medical Institute, other co-inventors are R. K. Chhetri and L. A. Royer). P.T. and A.C. declare no competing interests.


In this Review Article, the accept date was inadvertently omitted. It should be 18 November 2019. This error has been corrected online.

Attached Files

Accepted Version - nihms-1663171.pdf

Supplemental Material - 41583_2019_250_MOESM1_ESM.xlsx


Files (2.0 MB)
Name Size Download all
761.1 kB Download
1.2 MB Preview Download

Additional details

August 22, 2023
December 22, 2023